| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 18 May 2026 | 11 May 2026 |
| GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results for the quarter and year ended March 31, 2026. 2. The recommendation of final dividend, if any, on the equity share capital of the company for the FY 2025-26. Please find enclosed herewith the Outcome of Board Meeting held on May 18, 2026 (As Per BSE Annoncement Dated on:18.05.2026) | ||
| Board Meeting | 2 Feb 2026 | 27 Jan 2026 |
| GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve the Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 3rd quarter and nine months (Q3 & 9MFY26) ended December 31 2025. Please find enclosed Outcome of Board Meeting held on February 2, 2026. (As Per BSE Announcement Dated on: 02/02/2026) | ||
| Board Meeting | 8 Nov 2025 | 31 Oct 2025 |
| GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve 1. the Unaudited Financial Results along with Limited Review Report of the Statutory Auditor thereon of the Company for the 2nd quarter and half year ended on September 30, 2025; 2. the declaration of Interim dividend for the Financial Year 2025-26, if any, on the equity share capital of the company. Please find enclosed intimation for Declaration of Interim Dividend and Record Date. (As Per BSE Announcement Dated on 08.11.2025) | ||
| Board Meeting | 24 Sep 2025 | 24 Sep 2025 |
| Please find the enclosed herewith the Outcome of Board Meeting held on September 24, 2025 | ||
| Board Meeting | 6 Aug 2025 | 28 Jul 2025 |
| GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 1st quarter ended on June 30 2025. Please find enclosed outcome of Board Meeting held on August 6, 2025 (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 23 May 2025 | 14 May 2025 |
| GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve 1. Audited Financial Results for the quarter and year ended March 31 2025 2. The recommendation of final dividend if any on the equity share capital of the company for the FY 2024-25. Please find enclosed herewith Outcome of Board Meeting held on May 23, 2025 (As per BSE Announcement Dated on 23/05/2025) | ||
The building of this hospital shall be leased over for an extended period of time by GPT Healthcare so that uninterrupted services of its health sector might be rendered.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
